CF vs TELO · P/E 12, rev $5.94B vs $86.0M cap
CF Industries Holdings Inc (CF) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
TELO does not have a complete income-statement cache yet.
CF currently screens at market cap $14.98B and trailing P/E 12.2. TELO currently screens at market cap $86.0M.
Not investment advice. Open the CF and TELO stock pages for the full models.
Not investment advice.